郑州微飒生物科技有限责任公司 咨询热线：0371-88821766
行业动态

行业动态

追踪行业前沿，洞察产业趋势

代谢疾病Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension.

期刊：Journal of medicinal chemistry发表年份：2015作者：Tetsuo Asaki; Keiichi Kuwano; Keith Morrison; John Gatfield; Taisuke Hamamoto; Martine Clozel
阅读更多 →

代谢疾病A novel series of indazole-/indole-based glucagon receptor antagonists.

期刊：Bioorganic & medicinal chemistry letters发表年份：2015作者：Songnian Lin; Fengqi Zhang; Guoqiang Jiang; Sajjad A Qureshi; Xiaodong Yang; Gary G Chicchi; Laurie Tota; Alka Bansal; Edward Brady; Maria Trujillo; Gino Salituro; Corey Miller; James R Tata; Bei B Zhang; Emma R Parmee
阅读更多 →

代谢疾病MiR-34a is Involved in the Decrease of ATP Contents Induced by Resistin Through Target on ATP5S in HepG2 Cells.

期刊：Biochemical genetics发表年份：2015作者：Fengyun Wen; Bin Li; Chunyan Huang; Zhiguo Wei; Yingying Zhou; Jianyu Liu; Haiwei Zhang
阅读更多 →

代谢疾病Design, synthesis and structure-activity relationship studies of novel phenoxyacetamide-based free fatty acid receptor 1 agonists for the treatment of type 2 diabetes.

期刊：Bioorganic & medicinal chemistry发表年份：2015作者：Zheng Li; Xuekun Wang; Xue Xu; Jianyong Yang; Qianqian Qiu; Hao Qiang; Wenlong Huang; Hai Qian
阅读更多 →